L. Jay Katz named chief medical officer of Glaukos

L. Jay Katz, MD, FACS, has joined Glaukos as its chief medical officer, according to a company press release.the glaucoma service at Wills Eye Hospital and professor of ophthalmology at Jefferson Medical College at Thomas Jefferson University, previously served as a medical monitor for Glaukos clinical trials and an investigator for other glaucoma trials, including the Advanced Glaucoma Intervention Study and the Collaborative Initial Glaucoma Treatment Study.“Glaucoma is an insidious, asymptomatic disease that causes vision loss in millions of people worldwide,” Katz said in the release. “I have long admired and appreciated the innovative work Glaukos is undertaking to provide new, viable treatment options for glaucoma patients and the surgeons who care for them. I look forward to beginning the next phase of my career as part of the Glaukos organization as it continues to build MIGS awareness and adoption across the clinical community while also pursuing a range of promising next-generation therapies.”